Cargando…
The stable isotope method for determining absolute bioavailability
The bioavailability of a drug is usually assessed in healthy subjects. However, it is reasonable to expect that significant alterations in bioavailability may occur in actual patients with different diseases or in individuals belonging to special populations. Relatively few studies have been conduct...
Autor principal: | Atkinson, Arthur J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7042009/ https://www.ncbi.nlm.nih.gov/pubmed/32133319 http://dx.doi.org/10.12793/tcp.2017.25.2.53 |
Ejemplares similares
-
Intracerebroventricular drug administration
por: Atkinson, Arthur J.
Publicado: (2017) -
Augmented renal clearance
por: Atkinson, Arthur J.
Publicado: (2018) -
Elucidation of the pathophysiology of intradialytic muscle cramps: pharmacokinetics applied to translational research
por: Atkinson, Arthur J.
Publicado: (2019) -
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose
por: Roosendaal, Jeroen, et al.
Publicado: (2020) -
Power Determination During Drug Development: Is Optimizing the Sample Size Based on Exposure‐Response Analyses Underutilized?
por: Jones, Aksana K., et al.
Publicado: (2019)